Tans G - Search Results

1

Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.

Brugge JM, Simioni P, Bernardi F, Tormene D, Lunghi B, Tans G, Pagnan A, Rosing J, Castoldi E. Brugge JM, et al. Among authors: tans g. J Thromb Haemost. 2005 Dec;3(12):2695-702. doi: 10.1111/j.1538-7836.2005.01634.x. J Thromb Haemost. 2005. PMID: 16359508 Free article.

2

Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.

Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J. Curvers J, et al. Among authors: tans g. Thromb Haemost. 2002 Jul;88(1):5-11. Thromb Haemost. 2002. PMID: 12152677

3

Reduced factor V concentration and altered FV1/FV2 ratio do not fully explain R2-associated APC-resistance.

Govers-Riemslag JW, Castoldi E, Nicolaes GA, Tans G, Rosing J. Govers-Riemslag JW, et al. Among authors: tans g. Thromb Haemost. 2002 Sep;88(3):444-9. Thromb Haemost. 2002. PMID: 12353074

4

Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation.

Castoldi E, Govers-Riemslag JW, Pinotti M, Bindini D, Tans G, Berrettini M, Mazzucconi MG, Bernardi F, Rosing J. Castoldi E, et al. Among authors: tans g. Blood. 2003 Dec 1;102(12):4014-20. doi: 10.1182/blood-2003-04-1199. Epub 2003 Jul 24. Blood. 2003. PMID: 12881304 Free article.

5

Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.

Castoldi E, Brugge JM, Nicolaes GA, Girelli D, Tans G, Rosing J. Castoldi E, et al. Among authors: tans g. Blood. 2004 Jun 1;103(11):4173-9. doi: 10.1182/blood-2003-10-3578. Epub 2004 Feb 19. Blood. 2004. PMID: 14976057 Free article.

6

The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities.

Koenen RR, Gomes L, Tans G, Rosing J, Hackeng TM. Koenen RR, et al. Among authors: tans g. Thromb Haemost. 2004 Jun;91(6):1105-14. doi: 10.1160/TH04-02-0082. Thromb Haemost. 2004. PMID: 15175796

7

Protein S levels modulate the activated protein C resistance phenotype induced by elevated prothrombin levels.

Brugge JM, Tans G, Rosing J, Castoldi E. Brugge JM, et al. Among authors: tans g. Thromb Haemost. 2006 Feb;95(2):236-42. doi: 10.1160/TH05-08-0582. Thromb Haemost. 2006. PMID: 16493484

8

Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals.

Nicolaes GA, Thomassen MC, Tans G, Rosing J, Hemker HC. Nicolaes GA, et al. Among authors: tans g. Blood Coagul Fibrinolysis. 1997 Jan;8(1):28-38. doi: 10.1097/00001721-199701000-00006. Blood Coagul Fibrinolysis. 1997. PMID: 9105635

9

Coagulation factor V: an old star shines again.

Rosing J, Tans G. Rosing J, et al. Among authors: tans g. Thromb Haemost. 1997 Jul;78(1):427-33. Thromb Haemost. 1997. PMID: 9198191 Review.

10

Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.

Tans G, Nicolaes GA, Rosing J. Tans G, et al. Semin Hematol. 1997 Jul;34(3):244-55. Semin Hematol. 1997. PMID: 9241709 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters